Description: This session will address practical issues in genetic testing and therapy for cardiovascular diseases, including exercise safety, communicating the results of genetic tests for sudden cardiac death, and the role of pharmacogenomics. Experts will discuss the risks of genetic testing, the potential of gene therapy, and how to manage variants of uncertain significance (VUS).

Moderator:
Nosheen Reza (University of Pennsylvania)

Social Media Moderator(s):
Neha Hafeez (University of Pennsylvania)
Anna Kirillova (University of Pittsburgh)